coherus
biosciences
announces
new
employment
inducement
grants
redwood
city
globe
newswire
coherus
biosciences
coherus
company
nasdaq
chrs
today
announced
effective
october
compensation
committee
company
board
directors
granted
newly
hired
executive
vice
president
option
buy
shares
company
common
stock
per
share
exercise
price
closing
trading
price
grant
date
restricted
stock
units
newly
hired
senior
vice
president
granted
option
purchase
shares
company
common
stock
two
newly
hired
vice
presidents
granted
options
purchase
shares
company
common
stock
per
share
exercise
price
closing
trading
price
grant
date
aggregate
shares
common
stock
company
also
granted
seven
newly
hired
employees
per
share
exercise
price
closing
trading
price
grant
date
coherus
biosciences
coherus
leading
biologics
company
develops
commercializes
biosimilar
therapeutics
well
others
seeking
capable
access
united
states
market
composed
team
proven
industry
veterans
expertise
product
development
commercialization
coherus
positioned
leader
global
biosimilar
marketplace
headquartered
united
states
coherus
committed
reducing
healthcare
system
costs
expanding
patient
access
essential
therapeutics
coherus
commercialized
united
states
received
regulatory
approval
european
union
coherus
advancing
clinical
products
adalimumab
biosimilar
bioeq
ranibizumab
biosimilar
innovent
bevacizumab
biosimilar
towards
commercialization
company
also
advancing
clinical
products
including
aflibercept
biosimilar
additional
information
please
visit
contact
david
arrington
investor
relations
corporate
affairs
coherus
biosciences
darrington
